Normal levels of serum IGF-I: Determinants and validity of current reference ranges

Pituitary

Volumn 10, Issue 2, 2007, Pages 129-133

  Brabant, Georg ^a   Wallaschofski, H ^b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Age; Disease dependency; Gender; Genetics; IGF I; Nutrition

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; AGE; ARTICLE; CARCINOMA; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISEASE ACTIVITY; HEREDITY; HUMAN; KIDNEY FAILURE; LIVER CIRRHOSIS; LIVER FAILURE; NORMAL VALUE; NUTRITION; PRIORITY JOURNAL; PROTEIN DETERMINATION; REFERENCE VALUE; REPRODUCIBILITY; SEX DIFFERENCE; VALIDITY;

DISEASE SUSCEPTIBILITY; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 34249867419     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-007-0035-9     Document Type: Article

References (39)

1. Giustina A, Veldhuis JD (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19(6):717-797
2. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society (2000) GH Research Society. J Clin Endocrinol Metab 85(11):3990-3993
3. Shalet SM, Toogood A, Rahim A, Brennan BM (1998) The diagnosis of growth hormone deficiency in children and adults. Endocr Rev 19(2):203-223
4. Brabant G (2003) Insulin-like growth factor-I: Marker for diagnosis of acromegaly and monitoring the efficacy of treatment. Eur J Endocrinol 148(Suppl 2):S15-S20
5. Cohen P (2006) Overview of the IGF-I system. Horm Res 65(Suppl 1):3-8
6. Hwa V, Oh Y, Rosenfeld RG (1999) The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 20(6):761-787
7. Yakar S, Sun H, Zhao H, Pennisi P, Toyoshima Y, Setser J, Stannard B, Scavo L, Leroith D (2005) Metabolic effects of IGF-I deficiency: Lessons from mouse models. Pediatr Endocrinol Rev 3(1):11-19
8. Brabant G, von zur Muhlen A, Wuster C, Ranke MB, Kratzsch J, Kiess W, et al (2003) Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: Results from a multicenter study. Horm Res 60(2):53-60
9. Milani D, Carmichael JD, Welkowitz J, Ferris S, Reitz RE, Danoff A, Kleinberg DL (2004) Variability and reliability of single serum IGF-I measurements: Impact on determining predictability of risk ratios in disease development. J Clin Endocrinol Metab 89(5):2271-2274
10. Borofsky ND, Vogelman JH, Krajcik RA, Orentreich N (2002) Utility of insulin-like growth factor-1 as a biomarker in epidemiologic studies. Clin Chem 48(12):2248-2251
11. Smith PJ, Spurrell EL, Coakley J, Hinds CJ, Ross RJM, Krainer AR, Chew SL (2002) An exonic splicing enhancer in human IGF-I pre-mRNA mediates recognition of alternative exon 5 by the serine-arginine protein splicing factor-2/alternative splicing factor. Endocrinology 143:146-154
12. Hong Y, Brismar K, Hall K, Pedersen NL, de Faire U (1997) Associations between insulin-like growth factor-I (IGF-I), IGF-binding protein-1, insulin and other metabolic measures after controlling for genetic influences: Results from middle-aged and elderly monozygotic twins. J Endocrinol 153(2):251-257
13. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, Lamberts SW, Oostra BA, Pols HA, van Duijn CM (2001) A polymorphism in the gene for IGF-I: Functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 50(3):637-642
14. Lofqvist C, Andersson E, Gelander L, Rosberg S, Blum WF, Albertsson Wikland K (2001) Reference values for IGF-I throughout childhood and adolescence: A model that accounts simultaneously for the effect of gender, age, and puberty. J Clin Endocrinol Metab 86:5870-5876
15. Bereket A, Turan S, Omar A, Berber M, Ozen A, Akbenlioglu C, Haklar G (2006) Serum IGF-I and IGFBP-3 levels of Turkish children during childhood and adolescence: Establishment of reference ranges with emphasis on puberty. Horm Res 65:96-105
16. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, Muller J, Hall K, Skakkebaek NE (1994) Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: Relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78:744-752
17. Ranke MB, Osterziel KJ, Schweizer R, Schuett B, Weber K, Robbel P, Vornwald A, Blumenstock G, Elmlinger MW (2003) Reference levels of insulin-like growth factor I in the serum of healthy adults: Comparison of four immunoassays. Clin Chem Lab Med 41:1329-1334
18. Elmlinger MW, Kuhnel W, Weber MM, Ranke MB (2004) Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clin Chem Lab Med 42:654-664
19. Ho KK, Gibney J, Johannsson G, Wolthers T (2006) Regulating of growth hormone sensitivity by sex steroids: Implications for therapy. Front Horm Res 35:115-128
20. Caufriez A, Frankenne F, Hennen G, Copinschi G (1993) Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am J Physiol 265(4 Pt 1):E572-E577
21. Monaghan JM, Godber IM, Lawson N, Kaur M, Wark G, Teale D, Hosking DJ (2004) Longitudinal changes of insulin-like growth factors and their binding proteins throughout normal pregnancy. Ann Clin Biochem 41:220-226
22. Thissen JP, Ketelsleger JM (1994) Underwood LE Nutritional regulation of the insulin-like growth factors. Endocr Rev 15:80-101
23. Lieberman SA, Butterfield GE, Harrison D, Hoffman AR (1994) Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 78:404-410
24. Gianotti L, Broglio F, Ramunni J, Lanfranco F, Gauna C, Benso A, Zanello M, Arvat E, Ghigo E (1998) The activity of GH/IGF-I axis in anorexia nervosa and in obesity: A comparison with normal subjects and patients with hypopituitarism or critical illness. Eat Weight Disord 3:64-70
25. Ponzer S, Tidermark J, Brismar K, Soderqvist Cederholm T (1999) Nutritional status, insulin-like growth factor-I and quality of life in elderly women with hip fractures. Clin Nutr 18:241-246
26. Veldhuis JD, Iranmanesh A (1996) Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and sleep. Sleep 19(Suppl 10):S221-S224
27. Schneider HJ, Saller B, Klotsche J, Marz W, Erwa W, Wittchen HU, Stalla GK (2006) Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects. Eur J Endocrinol 154(5):699-706
28. de Boer H, Blok GJ, Voerman B, Derriks P, van der Veen E (1996) Changes in subcutaneous and visceral fat mass during growth hormone replacement therapy in adult men. Int J Obes Relat Metab Disord 20(6):580-587
29. Chen JW, Nielsen MF, Caumo A, Vilstrup H, Christiansen JS, Frystyk J (2006) Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis. Eur J Endocrinol 155:285-292
30. Barkan AL, Beitins IZ, Kelch RP (1988) Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: Correlation with the degree of growth hormone hypersecretion. J Clin Endocrinol Metab 67:69-73
31. Rabkin R, Schaefer F (2004) New concepts: Growth hormone, insulin-like growth factor-I and the kidney. Growth Horm IGF Res 14:270-276
32. Blum WF, Ranke MB, Kietzmann K, Tonshoff B, Mehls O (1991) Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia. Pediatr Nephrol 5:539-544
33. Heald AH, Anderson SG, Ivison F, Laing I, Gibson JM, Cruickshank K (2003) C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups. Atherosclerosis 170:79-86
34. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T (2002) Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: A population-based case-control study. Circulation 106(8):939-944
35. Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D (2004) The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: The Rancho Bernardo Study. J Clin Endocrinol Metab 89(1):114-120
36. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: Systematic review and meta-regression analysis. Lancet 363:1346-1353
37. Samani AA, Yakar S, LeRoith D, Brodt P (2007) The Role of the IGF System in Cancer Growth and Metastasis: Overview and recent insights. Endocr Rev 28:20-47
38. Jenkins PJ, Mukherjee A, Shalet SM (2006) Does growth hormone cause cancer? Clin Endocrinol (Oxf) 64:115-121
39. von Wichert G, Jehle PM, Hoeflich A, Koschnick S, Dralle H, Wolf E, Wiedenmann B, Boehm BO, Adler G, Seufferlein T (2000) Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells. Cancer Res 60:4573-4581